Pages that link to "Q39796348"

The following pages link to Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression (Q39796348):

Displaying 37 items.

• Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma. (Q33846310) (← links)
• Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach. (Q33980036) (← links)
• Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance (Q34105339) (← links)
• Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells (Q34303359) (← links)
• LAP2 is widely overexpressed in diverse digestive tract cancers and regulates motility of cancer cells (Q34321439) (← links)
• The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated. (Q34361840) (← links)
• Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma (Q34404633) (← links)
• Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein. (Q34805664) (← links)
• Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. (Q34857146) (← links)
• Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM (Q34992526) (← links)
• EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression (Q35078031) (← links)
• Long-term Cultured Human Neural Stem Cells Undergo Spontaneous Transformation to Tumor-Initiating Cells (Q35144727) (← links)
• A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis (Q36244135) (← links)
• Complex Oncogenic Signaling Networks Regulate Brain Tumor‐Initiating Cells and Their Progenies: Pivotal Roles of Wild‐Type EGFR, EGFRvIII Mutant and Hedgehog Cascades and Novel Multitargeted Therapies (Q36280796) (← links)
• Myristoylated Alanine-Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation (Q36835981) (← links)
• iTRAQ based quantitative proteomics approach validated the role of calcyclin binding protein (CacyBP) in promoting colorectal cancer metastasis (Q37001972) (← links)
• MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma (Q37130116) (← links)
• Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype via exosomal miR-21. (Q37327507) (← links)
• Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes. (Q37362563) (← links)
• MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis. (Q37437254) (← links)
• Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases (Q37544152) (← links)
• Migfilin sensitizes cisplatin-induced apoptosis in human glioma cells in vitro (Q37728696) (← links)
• Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights (Q37946264) (← links)
• Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations (Q38400600) (← links)
• Overcoming multiple myeloma drug resistance in the era of cancer 'omics'. (Q38671390) (← links)
• Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content (Q38843843) (← links)
• Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma (Q38960661) (← links)
• Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target (Q38976447) (← links)
• Expression of LOC285758, a Potential Long Non-coding Biomarker, is Methylation-dependent and Correlates with Glioma Malignancy Grade (Q41678161) (← links)
• A novel predictor of cancer malignancy: up-regulation of myristoylated alanine-rich C kinase substrate phosphorylation in lung cancer (Q42735841) (← links)
• Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers (Q47642445) (← links)
• MARCKS (Myristoylated Alanine-Rich C Kinase Substrate) and Lung Disease (Q58585938) (← links)
• Overexpression of MARCKS indicates a poor prognosis of oral squamous cell carcinoma (Q58772590) (← links)
• A Unique Family of Neuronal Signaling Proteins Implicated in Oncogenesis and Tumor Suppression (Q64105333) (← links)
• Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma (Q90239810) (← links)
• Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma (Q92815057) (← links)
• A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma (Q100737086) (← links)